Global Bone Densitometers Market - 2022-2029

Global Bone Densitometers Market - 2022-2029

Market Overview

The Bone Densitometers market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.1% during the forecast period (2022-2029).

A bone densitometer is a medical imaging device employed to measure bone density to determine if the patient has osteoporosis, a disorder indicated by more fragile bones that are more likely to break. The densitometer utilizes X-rays to estimate how many grams of calcium and other bone minerals are filled into a segment of bone.

Market Dynamics

The growing geriatric and post-menopausal women population fuels the bone densitometers market growth during the forecast period.

The growing geriatric population and post-menopausal women fuel global bone densitometer market growth.

The growing geriatric population and postmenopausal women fuel the global bone densitometer market growth. According to the American Academy of Orthopaedic Surgeons, most people reach their peak bone mass between the ages of 25 and 30 and by the time they reach age 40 slowly begin to lose bone mass, which increases with increasing age. As per the World Population Ageing 2020 Highlights, over 727 million persons were aged 65 years or above in 2020, and on average, women tend to live longer compared to men. They constitute most of the older persons, particularly at advanced ages. By 2050 the geriatric population is expected to reach 1.5 billion, more than double the geriatric population of 2020 and the share of the geriatric population is expected to rise from 9.3% in 2020 to approximately 16.0% in 2050. Thus, the growing geriatric population is driving the global bone densitometer market growth during the forecast period.

Furthermore, the growing number of postmenopausal women drives the global bone densitometer market growth. The end of a woman's menstrual cycle is called menopause. It is a natural biological process that happens in the 40s or 50s of women. Postmenopausal women are liable to primary osteoporosis as it is closely related to estrogen deficiency. In the menopausal transition period, the downfall in estrogen causes increased bone resorption, which leads to primary osteoporosis. Since the global geriatric population is increasing, especially the female geriatric population, it is boosting the global bone densitometer market growth during the forecast period.

The high cost of bone densitometer is hampering the global bone densitometer market growth.

However, the high cost of the bone densitometer is expected to hamper the global bone densitometer market growth during the forecast period. For instance, the early GE Prodigy Series, GE DPX series and Hologic Discovery series will cost around $16K to $21K. The later GE Prodigy series, later Hologic Discovery series and the early Hologic Horizon series cost $22K - $28K, while the latest GE Prodigy series, GE iDXA and Hologic Horizons A and W cost between $30K - $45K, thus, slowing the global bone densitometer market growth during the forecast period.

COVID-19 Impact.

The COVID-19 pandemic has greatly impacted the bone densitometer market since, according to the European Review for Medical and Pharmacological Sciences, there is the possibility of Secondary osteoporosis as a post-acute consequence of COVID-19. Thus, the bone health situation of patients outliving COVID-19 hospitalization needs to be observed closely at follow-up visits, facilitating the prevention and early treatment of osteoporosis complications. Furthermore, according to Indiana University researchers, even a mild infection of COVID-19 can cause rapid and significant bone density loss, according to long-term research. Therefore, increasing the need for monitoring the bone density of the patients who suffered COVID-19 infection, increasing the demand for bone densitometers and positively impacting the global bone densitometer market growth.

Segment Analysis

Dual-energy X-ray absorptiometry (DEXA) is estimated to dominate the global market during the forecast period (2022-2029).

Dual-energy X-ray absorptiometry (DEXA) is estimated to dominate the global bone densitometer market during the forecast period (2022-2029). Owing to the advantages of DEXA over other bone density meter techniques. DEXA measures the proportion of calcium and mineral in the bones by passing X-rays with two different energy levels from the bone. The advantages of DEXA over other techniques are its low radiation dose, accuracy and simplicity. Furthermore, compared with computed tomography and magnetic resonance imaging, the fat mass (FM) and lean mass (LM) values by DXA exhibit very good accuracy.

Moreover, according to Bone Journal, dual-energy X-ray absorptiometry (DXA) is considered the gold standard for estimating bone mineral density (BMD), diagnosing osteoporosis, and monitoring changes in BMD over time in the determination of fracture risk. In addition, ultrasound is less frequently used than DEXA since there are no precise guidelines to employ ultrasound measurement for diagnosing osteoporosis or predicting fracture risk. Therefore, concerning the above data, the DEXA will continue to dominate the global bone density meter market throughout the forecast period.

Geographical Analysis

North America is estimated to hold most of the global bone densitometers market share during the forecast period (2022-2029).

North America is expected to hold most of the global bone densitometer market share throughout the forecast period (2022-2029), owing to this region's growing post-menopausal female population. According to the North American Menopause Society, an estimated 6,000 US women reach menopause every day (more than 2 million annually). By 2026, it is estimated that almost one-quarter (22%) of the Canadian population will comprise women older than 50. Moreover, the existence of key market players such as OSI Systems, Inc., Tecnicare Healthcare Co., Hologic, Inc. and GE Healthcare which has held over a large portion of the bone densitometer market, ensure the dominance of this region over the bone densitometer market. These key players hold the major share of the market through various market strategies like product launches, partnerships, market approvals, acquisitions, collaborations, Etc. In addition, the new policy guidelines of different healthcare and insurance companies in the United States for the reimbursement of bone density studies are contributing to the dominance of this region over the global bone densitometers market. For instance, UnitedHealthcare, in September 2022, approved medicare coverage for Bone Mass Measurement (BMM) means a radiologic, radioisotopic, or other procedure. Thus, the data mentioned earlier indicate that North America has held over most of the global bone densitometer market share.

Competitive Landscape

The market's major key players are Some of the major manufacturers in the bone densitometers market are GE Healthcare, BeamMed, Diagnostic Medical System, Eco light Healthcare, Hologic Inc., Medonica, Osteosys, Swissray, OSI Systems, Inc. and Tecnicare Healthcare Co., among others. The key players are adopting various growth strategies such as new product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the global bone densitometers market. For instance, in April 2022, GE Healthcare inaugurated its new manufacturing plant in India.

GE Healthcare

Overview:

GE Healthcare is headquartered in Chicago, Illinois, United States, and was founded in 2004. It is a subsidiary of the American Multinational Conglomerate General Electric. It is a leading manufacturer and distributor of diagnostic imaging and radiopharmaceuticals for imaging modalities used in medical imaging procedures.

Product Portfolio:

GE Healthcare’s product portfolio for bone densitometers has Lunar iDXA: A state-of-the-art design that provides a high degree of clinical confidence across all body types for bone health and body composition, Prodigy: Prodigy provides precise soft tissue and bone composition data, including bone-mineral density (BMD), lean and fat-tissue mass, and fat percentage. At the same time, Prodigy streamlines patient care and practice workflow.

The global bone densitometers market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.